Muranen, TA, Morra, A
, Khan, SR, Barnes, DK, Bolla, M, Dennis, J, Keeman, R, Leslie, GT, Parsons, M, Wang, QU, Ahearn, T
, Aittomäki, K, Andrulis, IK, Arun, B, Behrens, S, Bialkowska, KE, Bojesen, SJ, Camp, N, Chang-Claude, J, Czene, K, Devilee, PM, Domchek, SM, Dunning, A, Engel, C, Evans, DG, Gago-Dominguez, M, Garcia-Closas, M, Gerdes, A-M, Glendon, G, Guenel, P, Hahnen, E, Hamann, U, Hanson, HJ, Hooning, M, Hoppe, R, Izatt, L, Jakubowska, AA, James, PN, Kristensen, V, Lalloo, FJ, Lindeman, G, Mannermaa, A, Margolin, SL, Neuhausen, SG, Newman, W, Peterlongo, P, Phillips, K-A, Pujana, MA, Rantala, J, Ronlund, K, Saloustros, EK, Schmutzler, R, Schneeweiss, AF, Singer, C
, Suvanto, M, Tan, YYR, Teixeira, M, Thomassen, M, Tischkowitz, M, Tripathi, V, Wappenschmidt, B, Zhao, EF, Easton, DC, Antoniou, A, Chenevix-Trench, G, Pharoah, PDPK, Schmidt, M
, Blomqvist, C & Nevanlinna, H 2023, '
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants',
Npj breast cancer, Vuosikerta 9, Nro 1, 37.
https://doi.org/10.1038/s41523-023-00546-x